Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
6.51
-0.21 (-3.12%)
At close: Dec 5, 2025, 4:00 PM EST
6.64
+0.13 (2.00%)
After-hours: Dec 5, 2025, 7:17 PM EST
Xeris Biopharma Holdings Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 1,080 | 505 | 325 | 181 | 365 | - | |
| Market Cap Growth | 140.71% | 55.70% | 79.47% | -50.50% | - | - | |
| Enterprise Value | 1,246 | 707 | 487 | 226 | 360 | - | |
| Last Close Price | 6.51 | 3.39 | 2.35 | 1.33 | 2.93 | - | |
| PS Ratio | 3.82 | 2.49 | 1.98 | 1.64 | 7.37 | - | |
| PB Ratio | - | -17.07 | -47.86 | 4.00 | 3.84 | - | |
| EV/Sales Ratio | 4.68 | 3.48 | 2.97 | 2.05 | 7.26 | - | |
| Debt / Equity Ratio | -299.25 | -9.17 | -33.79 | 4.38 | 0.93 | 2.58 | |
| Asset Turnover | 0.77 | 0.63 | 0.49 | 0.34 | 0.21 | 0.15 | |
| Inventory Turnover | 0.73 | 0.85 | 0.90 | 1.06 | 1.01 | 1.77 | |
| Quick Ratio | 1.25 | 1.12 | 1.17 | 2.08 | 1.52 | 4.99 | |
| Current Ratio | 1.93 | 1.67 | 1.64 | 2.54 | 1.80 | 5.40 | |
| Return on Equity (ROE) | - | - | -324.20% | -134.83% | -190.28% | -378.20% | |
| Return on Assets (ROA) | 2.88% | -5.33% | -8.25% | -15.78% | -28.45% | -38.02% | |
| Return on Capital (ROIC) | 3.98% | -7.42% | -11.81% | -24.01% | -43.37% | -52.67% | |
| Return on Capital Employed (ROCE) | 6.30% | -12.40% | -19.40% | -30.20% | -46.80% | -62.30% | |
| Earnings Yield | -1.45% | -10.85% | -19.18% | -52.34% | -33.59% | - | |
| FCF Yield | 0.92% | -7.49% | -15.18% | -57.18% | -26.44% | - | |
| Buyback Yield / Dilution | -8.48% | -6.61% | -1.51% | -71.62% | -85.32% | -63.32% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.